Detection of Streptococcus pyogenes M1


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
24 02 2023
Historique:
received: 21 09 2022
accepted: 13 02 2023
entrez: 24 2 2023
pubmed: 25 2 2023
medline: 3 3 2023
Statut: epublish

Résumé

A new variant of Streptococcus pyogenes serotype M1 (designated 'M1

Identifiants

pubmed: 36828918
doi: 10.1038/s41467-023-36717-4
pii: 10.1038/s41467-023-36717-4
pmc: PMC9951164
doi:

Substances chimiques

Superantigens 0
Bacterial Proteins 0
Exotoxins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1051

Informations de copyright

© 2023. The Author(s).

Références

J Appl Microbiol. 1997 Oct;83(S1):42S-51S
pubmed: 28621897
Lancet Infect Dis. 2020 May;20(5):538-539
pubmed: 32359463
Nat Genet. 2015 Jan;47(1):84-7
pubmed: 25401300
J Bacteriol. 2022 Jan 18;204(1):e0041821
pubmed: 34780302
Nat Med. 2007 Aug;13(8):981-5
pubmed: 17632528
PLoS One. 2016 Oct 5;11(10):e0163962
pubmed: 27706213
Lancet. 1992 Feb 29;339(8792):518-21
pubmed: 1346879
Lancet Infect Dis. 2020 May;20(5):539-540
pubmed: 32359464
Nucleic Acids Res. 2014 Jul;42(Web Server issue):W187-91
pubmed: 24799436
Bioinformatics. 2018 Sep 15;34(18):3094-3100
pubmed: 29750242
Mol Microbiol. 2007 Apr;64(2):269-80
pubmed: 17371500
Genome Biol. 2018 Oct 4;19(1):153
pubmed: 30286803
Infect Immun. 2001 Jan;69(1):534-7
pubmed: 11119547
Nucleic Acids Res. 2002 Feb 15;30(4):866-75
pubmed: 11842097
Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
Sci Rep. 2015 Nov 02;5:15877
pubmed: 26522788
Bioinformatics. 2012 Dec 15;28(24):3211-7
pubmed: 23071270
Emerg Infect Dis. 2008 Oct;14(10):1511-7
pubmed: 18826812
BMC Genomics. 2019 Mar 22;20(1):236
pubmed: 30902048
Lancet Microbe. 2022 May;3(5):e366-e375
pubmed: 35544097
Lancet Infect Dis. 2018 Feb;18(2):180-187
pubmed: 29191628
Genome Biol. 2014;15(12):550
pubmed: 25516281
J Infect Dis. 2005 Sep 1;192(5):771-82
pubmed: 16088826
RNA. 2022 Mar;28(3):400-417
pubmed: 34906997
Infect Genet Evol. 2020 Dec;86:104609
pubmed: 33147506
Mol Microbiol. 2015 Jan;95(2):270-82
pubmed: 25402410
Int J Infect Dis. 2020 Sep;98:305-314
pubmed: 32562850
Nat Rev Microbiol. 2011 Sep 16;9(10):724-36
pubmed: 21921933
Nat Genet. 2019 Jun;51(6):1035-1043
pubmed: 31133745
Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9223-7
pubmed: 7524073
Lancet Infect Dis. 2019 Nov;19(11):1209-1218
pubmed: 31519541
J Comput Biol. 2017 Nov;24(11):1138-1143
pubmed: 28715235
Infect Immun. 1986 Apr;52(1):144-50
pubmed: 3514452
Mol Microbiol. 1989 Nov;3(11):1481-5
pubmed: 2482406
Mol Microbiol. 1995 Oct;18(2):201-8
pubmed: 8709840
Euro Surveill. 2014 Mar 27;19(12):20749
pubmed: 24698137
Mol Microbiol. 1994 Feb;11(4):671-84
pubmed: 8196542
mBio. 2022 Jun 28;13(3):e0067622
pubmed: 35467425
Nat Commun. 2018 Sep 10;9(1):3676
pubmed: 30201986
J Infect Dis. 2012 Aug 1;206(3):341-51
pubmed: 22615319
Lancet Infect Dis. 2019 Dec;19(12):1284-1285
pubmed: 31782392
Mol Microbiol. 2001 Apr;40(1):99-114
pubmed: 11298279
Clin Infect Dis. 1992 Jan;14(1):298-307
pubmed: 1571445
EBioMedicine. 2018 Feb;28:128-135
pubmed: 29342444
Nat Commun. 2020 Oct 6;11(1):5018
pubmed: 33024089
Microbiol Spectr. 2019 May;7(3):
pubmed: 31111820
Bioinformatics. 2016 Oct 1;32(19):3047-8
pubmed: 27312411
Clin Microbiol Rev. 2014 Apr;27(2):264-301
pubmed: 24696436
J Clin Microbiol. 1996 Apr;34(4):953-8
pubmed: 8815115
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
Mol Biol Evol. 2018 Dec 1;35(12):3041-3043
pubmed: 30351396
Fly (Austin). 2012 Apr-Jun;6(2):80-92
pubmed: 22728672
J Mol Biol. 2001 Nov 9;313(5):1003-11
pubmed: 11700055
Annu Rev Biochem. 2007;76:101-24
pubmed: 17291191
F1000Res. 2019 Nov 7;8:1874
pubmed: 33552473
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430
Mol Biol Evol. 2020 Feb 1;37(2):599-603
pubmed: 31633786
Curr Opin Microbiol. 2017 Aug;38:66-73
pubmed: 28527384
FEMS Microbiol Rev. 2014 Sep;38(5):916-31
pubmed: 24617569
Gigascience. 2020 Feb 1;9(2):
pubmed: 32016399
Bioinformatics. 2011 Feb 15;27(4):592-3
pubmed: 21169378
Infect Immun. 1999 Oct;67(10):5495-9
pubmed: 10496938
J Bacteriol. 1999 Apr;181(7):2148-57
pubmed: 10094693
Bioinformatics. 2014 Jul 15;30(14):2068-9
pubmed: 24642063
Emerg Infect Dis. 2016 Jun;22(6):1075-8
pubmed: 27192393
Lancet Infect Dis. 2005 Nov;5(11):685-94
pubmed: 16253886
Front Genet. 2014 Apr 07;5:66
pubmed: 24778639
Bioinformatics. 2011 Apr 1;27(7):1009-10
pubmed: 21278367
Nucleic Acids Res. 2015 Feb 18;43(3):e15
pubmed: 25414349

Auteurs

Mark R Davies (MR)

Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia. mark.davies1@unimelb.edu.au.

Nadia Keller (N)

Australian Infectious Diseases Research Centre and School of Chemistry and Molecular Biosciences and Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia.

Stephan Brouwer (S)

Australian Infectious Diseases Research Centre and School of Chemistry and Molecular Biosciences and Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia.

Magnus G Jespersen (MG)

Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.

Amanda J Cork (AJ)

Australian Infectious Diseases Research Centre and School of Chemistry and Molecular Biosciences and Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia.

Andrew J Hayes (AJ)

Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.

Miranda E Pitt (ME)

Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.

David M P De Oliveira (DMP)

Australian Infectious Diseases Research Centre and School of Chemistry and Molecular Biosciences and Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia.

Nichaela Harbison-Price (N)

Australian Infectious Diseases Research Centre and School of Chemistry and Molecular Biosciences and Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia.

Olivia M Bertolla (OM)

Australian Infectious Diseases Research Centre and School of Chemistry and Molecular Biosciences and Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia.

Daniel G Mediati (DG)

School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW, Australia.

Bodie F Curren (BF)

Australian Infectious Diseases Research Centre and School of Chemistry and Molecular Biosciences and Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia.

George Taiaroa (G)

Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.

Jake A Lacey (JA)

Department of Infectious Diseases, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.

Helen V Smith (HV)

Public Health Microbiology, Queensland Health Forensic and Scientific Services, Queensland Health, Coopers Plains, QLD, Australia.

Ning-Xia Fang (NX)

Public Health Microbiology, Queensland Health Forensic and Scientific Services, Queensland Health, Coopers Plains, QLD, Australia.

Lachlan J M Coin (LJM)

Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.

Kerrie Stevens (K)

Microbiological Diagnostic Unit Public Health Laboratory, The Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.

Steven Y C Tong (SYC)

Department of Infectious Diseases, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
Victorian Infectious Diseases Service, The Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.

Martina Sanderson-Smith (M)

Illawarra Health and Medical Research Institute and Molecular Horizons, School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW, Australia.

Jai J Tree (JJ)

School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW, Australia.

Adam D Irwin (AD)

University of Queensland Centre for Clinical Research, Brisbane, QLD, Australia.
Queensland Children's Hospital, Brisbane, QLD, Australia.

Keith Grimwood (K)

School of Medicine and Dentistry and Menzies Health Institute Queensland, Griffith University, Gold Coast, QLD, Australia.
Departments of Infectious Diseases and Paediatrics, Gold Coast Health, Gold Coast, QLD, Australia.

Benjamin P Howden (BP)

Microbiological Diagnostic Unit Public Health Laboratory, The Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.

Amy V Jennison (AV)

Public Health Microbiology, Queensland Health Forensic and Scientific Services, Queensland Health, Coopers Plains, QLD, Australia.

Mark J Walker (MJ)

Australian Infectious Diseases Research Centre and School of Chemistry and Molecular Biosciences and Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia. mark.walker@uq.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH